Trials / Completed
CompletedNCT01126320
Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated Patients Using the AnapnoGuard System
Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated ICU Patients Using the AnapnoGuard System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 161 (actual)
- Sponsor
- Hospitech Respiration · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Ventilator Associated Pneumonia (VAP) is a common complication experienced by mechanically ventilated patients and within the framework of Respiratory Intensive Care Units. The AnapnoGuard system, developed by Hospitech Respiration Ltd. is a ventilation guard system that includes a number of unique characteristics. This study was designed to test the frequency VAP in mechanically ventilated ICU patients using the AnapnoGuard System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AnapnoGuard 100, | Respiratory guard system during mechanical ventilation with routine mechanical ventilator |
| DEVICE | routine mechanical ventilator | routine mechanical ventilation |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2015-07-01
- Completion
- 2015-12-01
- First posted
- 2010-05-19
- Last updated
- 2016-02-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01126320. Inclusion in this directory is not an endorsement.